申请人:KING ABDULAZIZ CITY FOR SCIENCE AND TECHNOLOGY
公开号:US20140296528A1
公开(公告)日:2014-10-02
The 4-aryl-1-(biarylmethylene)piperidine compounds are piperadine compounds having a biaryl substituent linked to the nitrogen atom of the piperidine ring by a methylene (—CH
2
—) group, and an aryl moiety attached to the 4-position of the piperidine ring. The aryl moiety may be a methoxy quinoline group, a 2-oxo quinoline group, or a 2-oxo, 3,4-dihydroxy quinoline group. The biaryl substituent may be biphenyl, fluorophenyl benzene, 3-phenyl pyridine, 3-(4-fluorophenyl) pyridine, phenyl cyclopentene, or 3-(1-cyclopenten-1-yl) pyridine. The compounds are believed to be suitable for anti-psychotic medication, since they are structurally related to SLV-313, a potential atypical antipsychotic having potent D
2
receptor antagonist and 5-HT
1A
receptor agonist properties.
4-芳基-1-(联苯基亚甲基)哌啶化合物是一类哌啶化合物,其具有通过一个亚甲基(—CH2—)基团连接到哌啶环的氮原子的联苯基取代基,并且一个芳基固定在哌啶环的4-位置。芳基可能是一个甲氧基喹啉基团,一个2-氧基喹啉基团,或一个2-氧基,3,4-二羟基喹啉基团。联苯基取代基可能是联苯,氟苯基苯,3-苯基吡啶,3-(4-氟苯基)吡啶,苯基环戊烯,或3-(1-环戊烯-1-基)吡啶。这些化合物被认为适用于抗精神病药物,因为它们在结构上与SLV-313相关,SLV-313是一种潜在的非典型抗精神病药物,具有强效的D2受体拮抗剂和5-HT1A受体激动剂特性。